JPD:GBA帕金森病患者,体位性低血压明显

2022-05-19 Freeman MedSci原创

GBA-PD患者从仰卧位转变为直立位时收缩压下降得更明显

葡萄糖苷酶(GBA)基因的变异是帕金森病(PD)发病最常见的遗传风险因素。在一项包括1,360名参与者的大型国际综合基因筛查研究中,8.5%的帕金森病患者被发现携带杂合的GBA变体,其中最常见的是c.1093G>A(p.Glu365Lys,也称为E326K)和c.1223C>T(p.Thr408Met,也称为T369M)。在最近的一项荟萃分析中发现,这两个变异体在非阿什肯纳齐犹太人群中显著增加PD的风险。

图1:论文封面图

直立性低血压(OH)被定义为在站立3分钟内收缩压持续下降至少20毫米汞柱或舒张压下降10毫米汞柱。在PD中,OH的发生率为30-40%,取决于病程和疾病的严重程度。与GBA相关的PD(GBA-PD)患者报告自律神经症状,如OH,比特发性PD(IPD)患者更频繁,程度更严重。

与这些报告相反,一项针对1435名PD患者的大型国际研究和最近的荟萃分析没有发现GBA-PD和IPD患者之间有不同的OH频率;然而,仍然不能确定如何评估OH。

OH与认知能力下降以及姿势不稳和步态困难表型(PIGD)有关。这些临床特征在GBA-PD中也比IPD中更常见。PD中的OH主要是由于心血管症状神经支配导致的肾上腺素缺乏的结果。

以前的一份报告发现,与IPD相比,GBA-PD的心肌(123)I-metaiodo-benzylguanidine摄取量有更大的减少,这表明GBA-PD的交感神经失调更为明显。

为了解决GBA-PD与IPD相比在OH发生率方面的矛盾,德国University of Lubeck的Tatiana Usnich等人,在以前描述的和同时扩大的PD队列中进行了OH分析。他们旨在评估GBA-PD与IPD相比,从仰卧位转为直立位时的血压变化,并捕捉在改变体位时发生的任何相关症状。

与特发性帕金森病患者(IPD)相比,携带葡萄糖脑苷脂酶(GBA)基因变体的帕金森病患者(GBA-PD)更频繁地出现正压症状。

他们对33名GBA-PD和313名IPD患者进行了前瞻性分析。

与IPD患者相比,GBA-PD患者从仰卧位转变为直立位时收缩压下降得更明显

图2:论文结果图

舒张压和心率在组间没有差异。

这项研究为GBA-PD中自律神经系统的明显参与提供了进一步证据。


原文出处:
on behalf of the EPIPARK Study Group, Usnich T, Hanssen H, et al. Pronounced Orthostatic Hypotension in GBA-Related Parkinson’s Disease. JPD. Published online April 28, 2022:1-6. doi:10.3233/JPD-223197

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
    2022-08-20 laiminchao

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
    2022-05-19 ms9000000795072041

    111

    3

    展开3条回复

相关资讯

JPD:低频率的前庭噪音刺激,或可改善帕金森患者姿势障碍

在接受低强度nGVS治疗的患者中,至少有一半的患者在姿势平衡方面表现出与SR相符的有力改善

JPD:人格测试,有助于帕金森病基本分类

早期帕金森病患者的性格使我们能够识别3种患者的表型

JPD:冷漠反映了新发帕金森病的纹状体外多巴胺能变性

孤立的帕金森病患者与纹状体外多巴胺能变性有关。

Neurology:神经丝光与帕金森病的发展和严重程度的关联

血液生物标记物可能有助于早期识别帕金森氏病(PD)、帕金森氏症及PD相关不良结局。近日,研究人员发现Nf-L与临床帕金森病、帕金森症状和身体功能下降有关。Nf-L或为神经退行性变潜在生物标记物。

JPD:帕金森患者的抑郁发病情况如何?

帕金森患者的患病率多少?

拓展阅读

European Radiology:弥散基础频谱成像检测早期帕金森病黑质和白质束的病理改变

为了解决弥散张量成像的局限性,研究发展了弥散基谱成像 (DBSI)以粗量化各向异性扩散张量反映轴突的完整性,其在多种中枢神经系统疾病中的敏感性和准确性已被证实。

帕金森病睡眠量表修订版(PDSS-2)

帕金森病睡眠量表修订版(PDSS-2)

神经科一周速递:热点解读进展大盘点!

一周热点分享 ,紧跟神经科学前沿,让每一次诊疗都更精准,点击立即查看!

早发性帕金森病临床变异性|疑难探究

发病年龄小于50岁的帕金森病被称为早发型帕金森病,发病年龄在21~50为青年型帕金森病,21岁以前发病的被称为少年型帕金森病。

帕金森病:想睡个好觉太难!

帕金森病(PD)患者昼夜节律的改变不仅会影响睡眠-觉醒周期调节,同样会对非运动症状造成影响。

论文解读|Huifang Shang教授团队最新研究揭示与帕金森病相关的PLXNA1基因的罕见变异

研究揭示了与神经系统疾病和帕金森综合症有关的PLXNA1基因罕见变异。

2024 NICE 诊断指南:帕金森病远程监测设备 [DG51]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-01-25

2023 NICE 技术鉴定指南:左旋多巴/卡比多巴组合治疗伴有运动症状的晚期帕金森病[TA934]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-11-29

帕金森病患者睡眠障碍评估与护理干预的最佳证据总结

浙江中医药大学护理学院 · 2023-08-10

早中期帕金森病患者运动管理的最佳证据总结

山东第一医科大学附属省立医院老年神经内科 · 2023-05-10